Declarations Ethics approval and consent to participate Not applicable
The pharma has previously announced that REDEFINE 1 is expected to read out by the end of the year, while data from REDEFINE 2 are expected in the first half of 2025
Methods: An expert working group (EWG) comprising ten pulmonologists and a multidisciplinary drafting committee reviewed data from in vitro , mechanistic, animal and observational studies, randomized trials, reviews and meta-analyses for role of NAC in respiratory diseases
Sun F, Wu S, Wang J, Guo S, Chai S, Yang Z, et al
Patient Selection for Treatment Modality in Stage III Non-small Cell Lung Cancer: A Population-based Analysis
Blin K, Shaw S, Steinke K, Villebro R, Ziemert N, Lee SY, et al